Turnstone Biologics Corp.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2021 | $80 M | No. 2 | $50 to $250 million | equity | SEC | |
| Jan 2019 | $42 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Turnstone Biologics Corp. chose not to state its revenue in its newest notice of a funding round (Jul 2021).
SEC Form D · Jul 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2021
That is all the official record says: Turnstone Biologics Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
13 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Fmr LLC | Fund or asset manager | not stated | not stated | Held Series B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Orbimed Advisors LLC | Fund or asset manager | not stated | not stated | Held Series B-1, B-2, C and D preferred (Form 3, 2023) | SEC Form 3 |
| OrbiMed Capital GP VI LLC | Fund or asset manager | not stated | not stated | Held Series B-1, B-2, C and D preferred (Form 3, 2023) | SEC Form 3 |
| Versant Affiliates Fund V, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Ophthalmic Affiliates I, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Vantage II GP-GP, LLC | Other | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Vantage II GP, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Vantage II, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Venture Capital V (Canada), LP | Venture capital | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Venture Capital V, L.P. | Venture capital | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Ventures V (Canada), L.P. | Venture capital | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Ventures V GP-GP (Canada), Inc. | Venture capital | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Versant Ventures V, LLC | Venture capital | not stated | not stated | Held Series A, B-1, B-2, C and D preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 23 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jose Manuel Otero | Executive officer | Jul 2021 |
| Maura Manuel Campbell | Executive officer | Jul 2021 |
| Michael Burgess | Executive officer | Jul 2021 |
| Sammy Farah | Executive officer | Jul 2021 |
| Jane Henderson | Executive officer | Jan 2019 |
| Jerel Davis | Director | Jul 2021 |
| Michael Burgess | Director | Jul 2021 |
| Patrick Machado | Director | Jul 2021 |
| Rishi Gupta | Director | Jul 2021 |
| Robert Gould | Director | Jul 2021 |
| Sammy Farah | Director | Jul 2021 |
| Stefan Larson | Director | Jul 2021 |
| Brad Bolzon | Director | Jan 2019 |